Problems displaying this message? View the online version.

Designing Drug Discovery

Are you involved in drug discovery?

Designing Drug Discovery Find out what academic innovators should know about emerging industry standards and practice for drug discovery.  Affiliate Assistant Professor Sheila Benson PhD and a team of pharmaceutical development experts from AMRI (Albany Molecular Research Institute) will explore the complexity of optimizing lead compounds and positioning leads for Investigational New Drug (IND) development.

Join Us to Learn About:

      1. The complexity of optimizing lead compounds
      2. How to position leads for IND development
      3. Industry standards and practice
      4. Challenges in early development
      5. When to outsource

Your Presenters

Sheila Benson, UW Affiliate Assistant Professor, brings years of experience in pharmaceutical development, and teaches drug development for the UW Bioengineering Department.  She has held positions at Burroughs Wellcome, G. D. Searle and TAP Pharmaceuticals. She has also served as a consultant to the pharma/biotech industry.

Michele Luche is the Scientific Director for AMRI’s Discovery Business Development team.  She has over 24 years of experience in drug discovery, including programs focused on oncology, inflammation, infectious disease, metabolic disorders and CNS targeted therapeutics.  Prior to joining AMRI in 2006, Michele held leadership positions at SUGEN (Pfizer) and CEPTYR (ICOS).    
Pete Guzzo is the Director of AMRI’s Integrated Drug Discovery team.  He has over 17 years of experience leading drug discovery teams at AMRI delivering innovative development compounds for partners.  He currently coordinates integrated drug discovery projects for strategic collaborations.
Susan Collins is Director of AMRI’s Drug Discovery Business Development team in North America.  She possesses over 22 years of experience in the life sciences industry, leading promotional and BD teams in both the commercial, branded pharmaceutical markets as well as the contract research organization (CRO) space.

Who Should Attend?

UW faculty, staff and students involved in pharmaceutical research and discovery. Also scientists and professionals from non-profit institutes and WA life sciences companies developing compounds or interested in drug development.

     Date: Friday, November 22nd
     Time: 3:30-5:30 PM
     Place: New Ventures Facility on the 3rd Floor of Fluke Hall - Map

Plan for a presentation followed by Q&A, then a happy hour with wine and light appetizers.

Online Access

ITHSOnline access is provided by the ITHS.  The ITHS is a partnership between the University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, and Seattle Children’s Hospital & Research Institute, and collaborates with regional institutions, communities, and tribal groups. The ITHS is supported by grants UL1TR000423, KL2TR000421, and TL1TR000422 from the NIH National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA).  For more visit:

Register Now

Space is limited - please register by November 14th.

Center for Commercialization
University of Washington
Phone (206) 543-0905

Manage Your Subscriptions/Unsubscribe